Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study

Myers, R. H., Schaefer, E. J., Wilson, P.W.F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A., Wolf, P. A.·1996·Neurology
DOI 10.1212/wnl.46.3.673

Cited by (346)

Items 301–346 of 346

  1. Diverting dementia
    Tamara S. Ritsema · 2018 · JAAPA
  2. Neurodegenerative and movement disorders
    2012 · CRC Press eBooks
  3. Epidemiology of Blood Lipids and Lipoproteins
    Peter W.F. Wilson · 2015 · Contemporary Endocrinology
  4. Association Between Pulse Pressure Values During the Acute Stroke Stage and Stroke Outcome
    Konstantinos N. Vemmos, Georgios K. Tsivgoulis, Konstantinos M. Spengos · 2004 · Stroke
  5. Does Preventing Stroke Prevent All Kinds of Dementia?
    Nandini Chakraborty · 2004 · Stroke
  6. EVALUATION OF HIGH-THROUGHPUT METHODOLOGY FOR MULTI-GENE SCREENING IN PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Leslie R. Fisher · 2011 · SUNScholar (Stellenbosch University)
  7. Counterpoint: Lipoproteins and dementia: Is there compelling evidence to treat Alzheimer's patients with statins?
    Peter W.F. Wilson, Gloria Lena Vega · 2008 · Journal of clinical lipidology
  8. Pathology of Brain Aging
    Janna H. Neltner, Peter T. Nelson · 2017 · Neurodegeneration
  9. Proteomic Identification of Plasma Proteins Associated with Future Dementia Development
    Joshua A. Bornhorst, Alicia Algeciras‐Schimnich · 2024 · Clinical Chemistry
  10. The relationship between age, cognitive function, cardiovascular fitness, and serum blood markers of cognitive function in healthy older adults
    David Michael Bellar · 2009 · OhioLink ETD Center (Ohio Library and Information Network)
  11. Genetic Risk Factors of Imaging Measures Associated with Late-Onset Alzheimer’s Disease
    Christiane Reitz · 2012 · InTech eBooks
  12. Function and brain structure in aging with and without cognitive impairment
    Cristina Solé‐Padullés · 2007 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  13. Lessons from single gene disorders
    Nicholas Dixon Hastie · 2007 · Cambridge University Press eBooks
  14. Epidemiology and Outcomes
    Robert David Stevens, Tarek Sharshar, E. Wesley Ely · 2013 · Cambridge University Press eBooks
  15. INVESTIGATION OF THE RELATIONSHIP OF CANDIDATE GENES ON CHROMOSOME 10 WITH THE RISK AND AGE-AT-ONSET OF ALZHEIMER'S DISEASE
    Ayla Öztürk · 2005 · D-Scholarship@Pitt (University of Pittsburgh)
  16. Complex phenotypic analysis to identify genes which contribute to or modify the development of Alzheimer's disease
    Paul Hollingworth · 2006 · ORCA Online Research @Cardiff (Cardiff University)
  17. Asociación del genotipo de la apolipoproteína E con la parálisis cerebral en el niño
    Maxine M. Kuroda, M. Weck, John F. Sarwark, Aaliyah Hamidullah, Mark S. Wainwright · 2007 · PEDIATRICS
  18. Estatinas y enfermedad de Alzheimer: ¿son concluyentes los estudios actuales?
    José María Mostaza, Carlos Lahoz · 2005 · Clínica e Investigación en Arteriosclerosis
  19. P3‐081: Education halves the risk of dementia due to apolipoprotein ∊4 allele: A collaborative study from the Swedish brain power initiative
    Hui‐Xin Wang, Deborah Gustafson, Miia Kivipelto, Nancy L. Pedersen, Ingmar Gr. Skoog, Bengt Windblad, Laura Fratiglioni · 2010 · Alzheimer s & Dementia
  20. Bibliography NIA/AlzA Conference on Apolipoprotein E Genotyping in Alzheimer's Disease
    Younga J. Kwon, Julia Tsai, Norman R. Relkin · 1996 · Annals of the New York Academy of Sciences
  21. A unified approach of meta-analysis: application to an antecedent biomarker study in Alzheimer's disease
    Chengjie Xiong, Gerald van Belle, Kejun Zhu, J. Philip Miller, John C. Morris · 2010 · Journal of Applied Statistics
  22. Observations on cerebral amyloid angiopathy and microvascular pathology in Alzheimer's disease and vascular dementia
    Mattias Haglund · 2005 · Lund University Publications (Lund University)
  23. Synaptic elimination and the complement system in Alzhaimer's disease
    Jonny Daborg · 2012 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  24. Delirium and dementia: unraveling the complex relationship
    Margaret A. Pisani · 2013 · Cambridge University Press eBooks
  25. Genetic Epidemiology of Neurologic Disease
    Lorene M. Nelson, Caroline M. Tanner, Stephen K. Van Den Eeden, Valerie M. McGuire · 2004 · Oxford University Press eBooks
  26. The Principle Syndromes of Dementia
    David S. Knopman · 2004 · Principles of Gender-Specific Medicine
  27. Estrogen Receptor β Regulates Brain Signaling Involved in Depression
    Anindit Chhibber · 2016 · KU ScholarWorks (The University of Kansas)
  28. C allele of the rs2209972 single nucleotide polymorphism of the insulin degrading enzyme gene and Alzheimer's disease in type 2 diabetes, a case control study
    Hugo Gutiérrez-Hermosillo, Enrique Díaz de León‐González, Rebeca Palacios‐Corona, Javier Armando Cedillo-Rodríguez, Abelardo Camacho‐Luis, Miguel Arturo Reyes-Romero, Juan Humberto Medina-Chávez, Pedro A. Blandón · 2015 · Medicina Clínica (English Edition)
  29. THE ASSOCIATION OF HABITUAL MILK INTAKE WITH THE RATE OF COGNITIVE DECLINE, AND RISK OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA.
    Natalia Petruski‐Ivleva · 2017 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  30. Smoking, pulmonary and heart diseases and the risk of cognitive impairment and dementia : an epidemiological approach
    Minna Rusanen · 2013 · UEF eRepo (University of Eastern Finland)
  31. Búsqueda de agonistas LXR en plantas colombianas con potencial terapéutico para la enfermedad de Alzheimer
    Bustos Rangel, Angie Milena · 2021
  32. Dementias
    Thomas J. Grabowski · 2009
  33. Apolipoprotein E
    Minerva M. Carrasquillo, Guojun Bu, Henrietta M. Nielsen · 2013 · Springer eBooks
  34. Dementias
    Thomas J. Grabowski, António R. Damásio · 2003
  35. References
    2012 · Duke University Press eBooks
  36. COVID-19 in structure of risk factors for cognitive impairment, methods of correction
    Pavel Rudolfovich Kamchatnov, Roman A. Cheremin, L. A. Skipetrova, А А Никонова, L. A. Pyshkina · 2022 · Medical alphabet
  37. Dementia
    Christopher I. Wright, Nhi‐Ha Trinh, Deborah Blacker, William E. Falk · 2008 · Elsevier eBooks
  38. Notes
    2012 · Duke University Press eBooks
  39. Delirium and Neurocognitive Disorders
    Howard CH Khoe, Cheryl WL Chang, Cyrus SH Ho · 2025 · Cambridge University Press eBooks
  40. Detection of the Alzheimer's disease soluble amyloid precursor protein and modulation of its proteolytic processing
    Taverna, Mara · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  41. Réorganisation des systèmes anatomo-fonctionnels et de la topologie cérébrale entre les formes à début précoce et tardif de maladie d'Alzheimer. : approche comportementale et en IRMf de repos
    Natalina Gour · 2013 · theses.fr (ABES)
  42. Landscape of Apolipoprotein (APOE) in the Emirati Population and Recommendations for a Genotyping Approach for Amyloid-Beta Monoclonal Antibodies (Aβ-mAbs) in Alzheimer’s Disease Patients
    Wadha Mohammed, Mohamed Al Ameri, Sahar Al Marzooqi, Habiba S. AlSafar, Roland Olbrich, Mira Mousa, Dalia Barayan, Tiago R. Magalhães, Javier Quilez, Judith Reche et al. · 2026 · Cureus
  43. Cognitive and motor profiles in biologically defined Parkinson's and Alzheimer's disease
    Daniel Zarhin, Noa Bregman, Tamara Shiner, Anat Mirelman, Roy N. Alcalay, Avner Thaler · 2026 · Journal of Parkinson s Disease
  44. Integrating Epidemiology with Genetics
    Ezra Susser, Sharon Schwartz, Alfredo Morabia, Evelyn J. Bromet · 2006
  45. A unifying hypothesis of alzheimer’s disease: III—Risk factors
    Heininger, Kurt · 2000 · Human Psychopharmacology: Clinical and Experimental
  46. Untitled work
    Sachdev · 1999 · 10.1002/(sici)1099-1166(199905)14:5